Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 2,821-2,832 of 10,592
Drug study icon
CompletedNCT01050582

Safety study of safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Schizophrenia

This study is completed in the United States, in Belgium, in Germany, .... It is testing safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation for Schizophrenia.

In United States
Schizophrenia, BipolarityDrugA study involving a medication or substance.From 8 Years to 16 Years
Countries
United States, Belgium, Germany, ...
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT01829048

Safety study of PF-02545920 in schizophrenia

This study is completed in the United States. It is testing PF-02545920 for schizophrenia.

In United States
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Pfizer
Condition
Schizophrenia
Drug study icon
CompletedNCT01518894

Safety study of PF-04958242 in schizophrenia

This study is completed in the United States. It is testing PF-04958242 for schizophrenia.

In United States
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Biogen
Condition
Schizophrenia
Drug study icon
CompletedNCT01880099

A Study to Help People Quit Smoking.

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Yale University
Condition
Addiction
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.